Research and Markets has announced the addition of the "Personalized Medicine's Effect on Oncologists' Treatment Regimens" report to their offering.

One aspect of personalized medicine is certain; it is complicated. If you happen to have a highly scientific background, you actually may be able to define the term. However, if you polled five people very familiar with personalized medicine, you should expect to hear five different definitions. The researcher wanted to understand where oncologists stand on the topic of personalized medicine.

101 US based, board-certified oncologists were interviewed to gather their views on how familiar they are with personalized medicine, how they are treating patients, what tests are being used and which will be used more, and how their patient treatment regimens could evolve in the future.

What You Will Learn:

- Oncologists' familiarity with personalized medicine, and perceptions related to hype vs. tangible benefit

- Future predictions for the use and benefits related to personalized medicine in oncology, including potential hurdles to adoption

- Percentage of patients requesting personalized medicine vs. percentage of oncologists suggesting personalized medicine to patients

- Current number of patients treated using genetic tumor profiling vs. oncologists' predictions for the number in 3 years

- Oncologists' interest in conducting clinical trials using genetic tumor profiling

- What tests oncologists perform, and how the data are used and stored for use in future clinical trials

Major Sections:

- Current Landscape

- Genetic Tests and Patient Care

- Clinical Trial Views

Key Topics Covered:

1. Copyright And Usage Guide

2. Introduction

3. Methodology

4. Statistical Significance

5. Respondent Qualifications

6. Current Landscape

7. Genetic Tests And Patient Care

8. Clinical Trial Views

9. Demographics

10. Just As We Were Going To Press

For more information about this report visit http://www.researchandmarkets.com/research/7zc257/personalized